Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ABBV-CLS-484 |
| Trade Name | |
| Synonyms | ABBV CLS 484|ABBV CLS484|AC484 |
| Drug Descriptions |
ABBV-CLS-484 is a PTPN2/PTPN1 inhibitor, which activates JAK/STAT signaling, leading to remodeling of the tumor microenvironment, and potentially activation of an antitumor immune response and tumor growth inhibition (PMID: 37794185). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C179723 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ABBV-CLS-484 | ABBV-CLS-484 | 0 | 1 |
| ABBV-CLS-484 + unspecified PD-1 antibody | ABBV-CLS-484 unspecified PD-1 antibody | 0 | 1 |
| ABBV-CLS-484 + unspecified VEGFR inhibitor | ABBV-CLS-484 unspecified VEGFR inhibitor | 0 | 1 |